We are delighted to announce that LS CancerDiag has been selected as a participant to the EIT Health Bridgehead Europe programme!
LS CancerDiag is excited to join this excellent programme for the second time! After Bridgehead Global, where the company explored the North American market, the European edition will provide another critical contribution to our expansion efforts in bringing DiagMMR® to hospitals across Europe and beyond.
You can find the announcement on the EIT Health news website.
Given the strategic importance of the UK market in advancing Lynch syndrome research, screening and clinical care of affected families, we are happy to announce our collaboration with the Innovation Agency in this project, they are the Academic Health Science Network for the North West Coast, one of England’s 15 AHSNs in the AHSN Network which collectively acts as the innovation arm of the NHS.
About the Innovation Agency
The Innovation Agency is the Academic Health Science Network for the North West Coast, one of England’s 15 AHSNs in the AHSN Network which collectively acts as the innovation arm of the NHS. Commissioned by NHS England and Improvement, the Office for Life Sciences and the European Regional Development Fund to deliver programmes, support and innovations for adoption and spread in their region.
About Bridgehead Europe
EIT Health’s Bridgehead brings together European health entrepreneurs who want to grow their business beyond their home market with the world’s top incubators and accelerators who have the expertise and resources to make it happen. Bridgehead Europe drives the expansion of scale-up ventures from one European market into another through partners with local knowledge.
About EIT Health
EIT Health is a network of best-in-class health innovators with approximately 150 partners and is supported by the European Institute of Innovation and Technology (EIT), a body of the European Union. We collaborate across borders to deliver new solutions that can enable European citizens to live longer, healthier lives.
As Europeans tackle the challenge of increasing chronic diseases and multi-morbidity, and seek to realise the opportunities that technology offers to move beyond conventional approaches to treatment, prevention and healthy lifestyles, we need thought leaders, innovators and efficient ways to bring innovative healthcare solutions to market.
EIT Health addresses these needs. We connect all relevant healthcare players across European borders – making sure to include all sides of the “knowledge triangle”, so that innovation can happen at the intersection of research, education and business for the benefit of citizens.
EIT Health: Together for healthy lives in Europe.
For more information visit: www.eithealth.eu.